Functionalization of Methylene Bridges of Calix[6]arene Scaffold
125 MHz) δ 154.0, 145.7, 133.4, 126.0, 60.0, 34.1, 31.4 ppm.
HRMS (ESI) m/z 1085.7476 [(M + Na)+, calcd for C72H90D6NaO6,
1085.7475].
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexakis(2,5-dimethylphenyl)calix[6]arene (11). Yield
1
86 mg (78%). Mp 383 °C (dec). H NMR (CDCl3, 500 MHz) δ
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexaazido-calix[6]arene (6). A mixture of 3 (0.10
g, 0.07 mmol), sodium azide (0.20 g, 3.08 mmol), 18-crown-6 (0.81
g, 3.08 mmol), and 10 mL of TFE was heated at reflux for 18 h.
After evaporation of the solvent, the residue was dissolved in 30
mL of chloroform and washed twice with 1 M aqueous HCl. Three
recrystallizations from CHCl3/MeOH yielded 18 mg (22%) of 6
6.96 (s, 6H), 6.89 (d, J ) 7.5 Hz, 6H), 6.80 (d, J ) 8.5 Hz, 6H),
6.76 (s, 6H), 6.59 (s, 6H), 6.38 (s, 6H), 2.88 (s, 9H), 2.50 (s, 9H),
2.15 (s, 18H), 2.02 (s, 18H), 1.05 (s, 27H), 0.95 (s, 27H) ppm. 13
C
NMR (CDCl3, 100 MHz,) δ 153.6, 153.2, 145.4, 145.1, 143.8,
136.4, 135.2, 134.1, 133.6, 130.0, 129.2, 126.3, 126.0, 125.9, 60.5,
60.0, 40.4, 34.2, 31.3, 21.2, 18.8 ppm. HRMS (ESI) m/z 1682.0991
(M+, calcd for C120H144NaO6, 1682.0962).
1
95% pure. Mp 182-185 °C. H NMR (CDCl3, 500 MHz) δ 7.30
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexakis(2,3,4,5-tetramethylphenyl)calix[6]arene (12).
A reaction was carried out as described in the general procedure.
After evaporation of the solvent, the residue was recrystallized from
(s, 12H), 6.42 (s, 6H), 3.33 (s, 18H), 1.10 (s, 54H) ppm.13C NMR
(CDCl3, 125 MHz) δ 152.9, 147.3, 132.2, 125.8, 61.7, 56.1, 34.5,
31.2 ppm. HRMS (ESI) m/z 1325.7183 [(M + Na)+, calcd for
C72H90N18NaO6, 1325.7188].
1
C6H6/MeOH yielding 69 mg (57%) of 12. Mp 376 °C (dec). H
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexaanilino-calix[6]arene (7). A mixture of 3 (0.20
g, 0.07 mmol), aniline (0.25 g, 2.74 mmol), and 30 mL of TFE
was heated at reflux for two h. Chloroform was added, and the
organic phase was washed twice with water. After drying (MgSO4)
and evaporation of the solvent, the residue was recrystallized from
CHCl3/MeOH yielding 36 mg (34%) of the hexaanilino derivative
NMR (C6D6, 400 MHz) δ 7.46 (s, 6H), 7.34 (s, 6H), 7.03 (s, 6H),
6.82 (s, 6H), 3.17 (s, 9H), 2.92 (s, 9H), 2.39 (s, 18H), 2.21 (s,
18H), 2.01 (s, 18H), 1.98 (s, 18H), 1.26 (s, 27H), 1.11 (s, 27H)
ppm. 13C NMR (C6D6, 125 MHz) δ 154.0, 153.8, 145.4, 145.1,
141.5, 137.6, 136.7, 135.2, 132.7, 132.3, 132.2, 128.5, 126.4, 60.5,
60.1, 41.2, 34.5, 34.2, 31.6, 31.3, 21.0, 16.2, 15.8, 15.6 ppm.
MALDI MS, m/z 1875.5 (M + Na)+.
1
7. Mp 383 °C. H NMR (CDCl3, 500 MHz) δ 7.28 (s, 12H), 7.08
(t, J ) 8.0 Hz, 12H), 6.64 (t, J ) 7.5 Hz, 6H), 6.54 (d, J ) 7.0 Hz,
12H), 6.47 (d, J ) 6.0 Hz, 6H), 4.08 (d, J ) 5.5 Hz, 6H), 3.14 (br
s, 18H), 1.04 (s, 54H) ppm. 13C NMR (CDCl3, 100 MHz) δ 153.7,
146.7, 146.5, 135.0, 129.0, 124.7, 117.5, 113.3, 61.5, 49.3, 34.3,
31.2 ppm. HRMS (ESI) m/z 1603.9767 [(M)+, calcd for
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexakis-(2-methoxy-4-methylphenyl)calix[6]arene
(13). Yield 68 mg (59%). Mp 390 °C (dec). 1H NMR (CDCl3, 400
MHz) δ 6.86 (d, Jo ) 8.4 Hz, Jm ) 2.0 Hz, 6H), 6.82 (br s, 12H),
6.62 (d, Jo ) 8.8 Hz, 6H), 6.55 (s, 6H), 6.51 (s, 6H), 3.48 (s, 18H),
2.13 (s, 18H), 0.99 (br s, 54H) ppm.13C NMR (CDCl3, 125 MHz,
238K) δ 155.0, 153.3, 152.9, 144.9, 144.2, 136.2, 134.0, 130.1,
128.5, 127.0, 125.7, 124.7, 111.0, 60.4, 60.0, 56.1, 34.2, 34.2, 31.5,
31.3, 21.1 ppm. HRMS (ESI) m/z 1801.0584 [(M + Na)+, calcd
for C120H144NaO12, 1801.0555].
C
108H126N6O6, 1603.9738].
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexaacetoxy-calix[6]arene (8). Calixarene 3 (1.5 g,
0.98 mmol) and 200 mL of acetic acid were heated at reflux for
18 h. After cooling, the acetic acid was evaporated, and the residue
was recrystallized from CHCl3/MeOH to yield 0.38 g of the
hexaacetoxy derivative 8 (28%). Mp 392 °C (dec). 1H NMR
(CDCl3, 400 MHz) δ 7.52 (s, 6H), 7.26 (s, 12H), 3.66 (s, 18H),
2.08 (s, 18H), 1.12 (s, 54H) ppm. 13C NMR (CDCl3, 125 MHz) δ
169.5, 153.5, 146.6, 132.8, 125.3, 66.3, 61.7, 34.4, 31.3, 20.9 ppm.
HRMS (ESI) m/z 1427.7424 [(M + Na)+, calcd for C84H108NaO18,
1427.7433].
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexahydroxy-calix[6]arene (9). To an ice-cold solu-
tion of 8 (0.36 g, 0.27 mmol) in 50 mL of dry THF was added
LiAlH4 (0.11 g, 2.89 mmol) under an inert atmosphere, and the
mixture was stirred for 30 min. Ethyl acetate was added to quench
the excess of LiAlH4, and the solution was washed with water,
and then with 1 M aq HCl. After drying (MgSO4) the organic phase
was filtered and evaporated. Recrystallization from CHCl3/MeOH
yielded 0.15 g of 9 (51%). Mp 348 °C (dec). 1H NMR (DMSO-d6,
500 MHz) δ 7.24 (s, 12H), 6.32 (d, J ) 6.0 Hz, 6H), 5.51 (d, J )
6.0 Hz, 6H), 3.01 (br s, 18H), 1.05 (s, 54H) ppm. 13C NMR
(CD3OD, 125 MHz) δ 152.4, 145.4, 135.6, 124.2, 63.0, 60.8, 33.6,
30.1 ppm. HRMS (ESI) m/z 1175.6794 [(M + Na)+, calcd for
C72H96NaO12, 1175.6799].
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexamesityl-calix[6]arene (14). Yield 75 mg (66%).
1
Mp 405 °C (dec). H NMR (CDCl3, 500 MHz) δ 7.12 (s, 6H),
7.07 (s, 6H), 6.69 (s, 6H), 6.59 (s, 6H), 6.47 (s, 6H), 2.58 (s, 9H),
2.21 (s, 18H), 2.18 (s, 9H), 2.13 (s, 18H), 2.08 (s, 18H), 1.15 (s,
27H), 0.91 (s, 27H) ppm. 13C NMR (CDCl3, 100 MHz) δ 155.7,
152.7, 145.9, 143.3, 138.6, 138.0, 137.3, 135.9, 135.4, 134.9, 131.0,
129.5, 127.9, 126.2, 60.4, 60.3, 40.7, 34.3, 34.0, 31.4, 27.3, 21.0,
20.6 ppm. HRMS (ESI) m/z 1789.1828 [(M + Na)+, calcd for
C
126H156NaO6, 1789.1799].
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexakis-(2,4-pentanedione-3-yl)calix[6]arene (15). A
mixture of 3 (0.10 g, 0.07 mmol), 1 mL of 2,4-pentanedione, and
10 mL of TFE was heated at reflux for 2 h. After evaporation of
the solvents, the residue was recrystallized from CHCl3/MeOH
yielding 55 mg (51%) of 15. When HFIP was used instead of TFE
as a solvent the yield of 15 was 67 mg (62%). Mp 260-262 °C.
1H NMR (CDCl3, 400 MHz) δ 7.19 (s, 12H), 5.51 (d, J ) 12.0
Hz, 6H), 4.39 (d, J ) 11.6 Hz, 6H), 4.10 (s, 18H), 2.02 (s, 36H),
1.14 (s, 54H). 13C NMR (CDCl3, 125 MHz) δ 202.8, 152.7, 146.3,
133.8, 124.7, 77.6, 60.6, 36.7, 34.4, 31.0, 29.8 ppm. HRMS (ESI)
m/z 1668.9318 [(M + Na)+, calcd for C102H132NaO18, 1668.9311].
General Procedure for the Preparation of the Hexaaryl Deriva-
tives 10-14. A mixture of 3 (0.10 g, 0.07 mmol), 2 mL of HFIP,
8 mL chloroform, and 1 mL of the appropriate reagent was heated
at reflux for 2 h. After evaporation of the solvent, the residue was
recrystallized from CHCl3/MeOH.
Acknowledgment. We thank Dr. Shmuel Cohen (Hebrew
University) for the crystal structure determinations. This research
was supported by the Israel Science Foundation (grant No.
934/04).
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,40,41,42-hexamethoxy-
2,8,14,20,26,32-hexakis(2,4-dimethylphenyl)calix[6]arene (10). Yield
1
74 mg (67%). Mp 385 °C (dec). H NMR (CDCl3, 400 MHz) δ
6.97 (s, 6H), 6.81 (m, 12H), 6.78 (s, 6H), 6.73 (d, J ) 8.2 Hz,
6H), 6.37 (s, 6H), 2.84 (s, 9H), 2.45 (s, 9H), 2.20 (s, 18H), 2.06 (s,
18H), 1.04 (s, 27H), 0.92 (s, 27H) ppm. 13C NMR (CDCl3, 125
MHz, 233 K) δ 153.3, 153.1, 145.1, 144.9, 140.8, 136.2, 136.1,
135.0, 134.6, 131.0, 128.1, 126.0, 125.9, 125.6, 60.7, 59.7, 39.5,
34.3, 34.2, 31.4, 31.3, 21.1, 19.7 ppm. MALDI MS, m/z 1705.0
(M + Na)+.
Supporting Information Available: 1H and 13C NMR
spectra of 4a-k and 5-15 and molecular structures of 4a and
14. This material is available free of charge via the Internet at
JO801187Z
J. Org. Chem. Vol. 73, No. 18, 2008 7335